Invasive Hemodynamics and Rejection Rates in Patients with Cardiac Sarcoidosis After Heart Transplantation
Conclusions CS patients have similar post-transplant hemodynamics as non-CS patients, without evidence of RV dysfunction or pulmonary hypertension. No significant rejection nor recurrence of sarcoid in the allograft were observed in this cohort of patients with CS. Survival is similar between CS and non-CS patients. Heart transplant is a viable strategy in selected CS patients with excellent outcomes. Teaser Orthotopic heart transplant (OHT) is utilized for end-stage heart failure due to cardiac sarcoidosis (CS). There is a lack of data on long-term outcomes. We explored changes in hemodynamics, allograft rejection and survival after OHT in CS. CS patients have similar post-transplant hemodynamics as non-CS patients. No significant rejection nor recurrence of CS were observed. Survival is similar between CS and non-CS patients. Heart transplant is a viable strategy in selected CS patients.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Bone Graft | Canada Health | Cardiology | Cardiomyopathy | Heart | Heart Failure | Heart Transplant | Hypertension | Ischemic Stroke | Pulmonary Hypertension | Sarcoidosis | Stroke | Transplant Surgery | Transplants